LRCX vs NVDA
LRCX and NVDA side by side — valuation & fundamentals (public data).
Key statistics
| Metric | LRCXLAM RESEARCH CORPORATION | NVDANVIDIA CORP |
|---|---|---|
| Market cap | $289.23B | $4.97T |
| P/E (TTM) | 34.5 | 26.0 |
| P/B | 20.80 | 21.68 |
| P/S | 12.8x | 23.0x |
| Dividend yield | 0.44% | 0.02% |
| Revenue | $26.13B(TTM) | $302.97B(TTM) |
| Revenue growth (YoY) | 26.0% | 65.5% |
| Net income | $8.45B(TTM) | $192.88B(TTM) |
| Earnings growth (YoY) | 35.6% | 64.7% |
| EPS, diluted | $6.71(TTM) | $7.91(TTM) |
| EBIT margin | 35.3% | 60.4% |
| ROE | 52.2% | 52.4% |
| ROIC | 65.4% | 46.1% |
| Piotroski F | 8/9 | 4/9 |
| 1y total return | +51.9% | +1.8% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: LRCX frente a NVDA
| Métrica | LRCX | NVDA |
|---|---|---|
| Valor final | $315.8K | $1.79M |
| Retorno total | +3058.3% | +17833.1% |
| CAGR | +39.6% | +65.2% |
| Volatilidad | 46.4% | 49.5% |
| Sharpe | 0.86 | 1.18 |
| Sortino | 1.28 | 1.80 |
| Caída máxima | -56.4% | -66.3% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)